ArticleBriefings in bioinformatics2025
Benchmarking large language models for cell typing in single-cell RNA-Seq.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liquid biopsy in modern medicine: advancing diagnostics from molecular insights to clinical practice.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Large language models (LLMs) show significant potential for cell type annotation in single-cell RNA sequencing (scRNA-seq), but a systematic framework for their application and a comprehensive performance comparison are lacking. Here, we systematically benchmarked seven leading LLM models and three traditional bioinformatics tools across 34 diverse human and mouse datasets. We establish that using marker genes selected by statistical significance and ranked by log₂ fold change optimizes annotation accuracy. Our benchmark reveals that LLMs profoundly outperform traditional methods, particularly in resolving fine-grained cell subtypes. A top tier of models, including Kimi-k2, GPT-5, Claude-4.1, and Grok-4, consistently delivered the highest accuracy. To harness their collective strength, we developed an elite ensemble strategy that achieves state-of-the-art performance. We encapsulated these findings into DeepCellSeek, an open-source R package and interactive web platform, to provide a validated, high-performance solution. This work provides a practical roadmap for leveraging LLMs in single-cell research and paves the way for their evolution into powerful discovery engines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.